# Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.

> **NCT05317611** · NA · COMPLETED · sponsor: **Zagazig University** · enrollment: 63 (actual)

## Conditions studied

- Prevention

## Interventions

- **DRUG:** Intraperitoneal instillation of ondansetron and bupivacaine
- **DRUG:** Intravenous ondansetron and intraperitoneal instillation of bupivacaine
- **DRUG:** Intraperitoneal instillation of bupivacaine

## Key facts

- **NCT ID:** NCT05317611
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2025-01-15
- **Final completion:** 2025-01-26
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05317611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05317611, "Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05317611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*